Supplementary Methods-S1-15 and Tables-S1-4 from &lt;i&gt;ASS1&lt;/i&gt; as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance